CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 381 enrolled
Drug / intervention
THERMOCOOL SMARTTOUCH® SF catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02817776
NCT02817776N/ACompleted
CompareCT.gov

Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF (STSF) Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT)

Biosense Webster, Inc.·interventional·Posted Jun 29, 2016·Updated Feb 4, 2025

In Brief

A clinical study evaluating THERMOCOOL SMARTTOUCH® SF catheter for Atrial Fibrillation. Completed, enrolled 381 participants.

Detailed Summary

This is a prospective, multicenter, non-randomized clinical evaluation utilizing the THERMOCOOL SMARTTOUCH® SF catheter compared to a predetermined performance goal.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 29, 2016
Enrollment StartJun 1, 2016
Primary CompletionJun 5, 2019
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 10.0 years ago

Interventions

THERMOCOOL SMARTTOUCH® SF catheterdevice

Radiofrequency Ablation